• Research Topics

Found 4650 Results
Page 6 of 47

orcid publication

Silencing phosphodiesterase 7B gene by lentiviral-shRNA interference attenuates neurodegeneration and motor deficits in hemiparkinsonian mice.

orcid publication

Phosphodiesterase 7 Inhibition Induces Dopaminergic Neurogenesis in Hemiparkinsonian Rats

orcid publication

PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis

orcid publication

Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE-1 and GSK-3 beta Inhibitors

orcid publication

Morphometric and neurochemical alterations found in L-BMAA treated rats

orcid publication

Impairments in cognition and neural precursor cell proliferation in mice expressing constitutively active glycogen synthase kinase-3

orcid publication

From Bitopic Inhibitors to Multitarget Drugs for the Future Treatment of Alzheimer's Disease

orcid publication

Chapter 9. Heterocycles Containing Nitrogen and Sulfur as Potent Biologically Active Scaffolds

orcid publication

Biology-oriented development of novel lipophilic antioxidants with neuroprotective activity

orcid publication

Analysis of β-N-methylamino-l-alanine (L-BMAA) neurotoxicity in rat cerebellum

orcid publication

3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3 beta Fragment Hits against Alzheimer's Disease

orcid publication

Therapeutic approaches for the future treatment of Fragile X

orcid publication

Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3 beta Inhibitors

orcid publication

Tideglusib, a chemical inhibitor of GSK3beta, attenuates hypoxic-ischemic brain injury in neonatal mice.

orcid publication

The GSK-3-inhibitor VP2.51 produces antidepressant effects associated with adult hippocampal neurogenesis.

orcid publication

Targeting TDP-43 phosphorylation by Casein Kinase-1 delta inhibitors: a novel strategy for the treatment of frontotemporal dementia

orcid publication

Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior

orcid publication

Small GSK-3 Inhibitor Shows Efficacy in a Motor Neuron Disease Murine Model Modulating Autophagy

orcid publication

Novel Triazole-Quinoline Derivatives as Selective Dual Binding Site Acetylcholinesterase Inhibitors.

orcid publication

Enhancing cAMP Levels as Strategy for the Treatment of Neuropsychiatric Disorders

orcid publication

Development of Blood-Brain Barrier Permeable Nitrocatechol-Based Catechol O-Methyltransferase Inhibitors with Reduced Potential for Hepatotoxicity

orcid publication

Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa

orcid publication

Promoting in vivo remyelination with small molecules: a neuroreparative pharmacological treatment for Multiple Sclerosis.

orcid publication

Phosphodiesterase7 Inhibition Activates Adult Neurogenesis in Hippocampus and Subventricular Zone In Vitro and In Vivo

orcid publication

Pharmacological tools based on imidazole scaffold proved the utility of PDE10A inhibitors for Parkinson's disease

orcid publication

Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents.

orcid publication

Intranasal siRNA administration reveals IGF2 deficiency contributes to impaired cognition in Fragile X syndrome mice

orcid publication

Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome

orcid publication

Inhibition of hippocampal long-term potentiation by high-fat diets: is it related to an effect of palmitic acid involving glycogen synthase kinase-3?

orcid publication

GSK-3 inhibitor TDZD-8 reduces neonatal hypoxic-ischemic brain injury in mice

orcid publication

From dual binding site acetylcholinesterase inhibitors to allosteric modulators: A new avenue for disease-modifying drugs in Alzheimer's disease

orcid publication

Drugs in clinical development for the treatment of amyotrophic lateral sclerosis

orcid publication

Chapter 8. Medicinal Chemistry Strategies to Discover New Leishmanicidal Drugs

orcid publication

A preliminary investigation of phoshodiesterase 7 inhibitor VP3.15 as therapeutic agent for the treatment of experimental autoimmune encephalomyelitis mice.

orcid publication

Subtly Modulating Glycogen Synthase Kinase 3 β: Allosteric Inhibitor Development and Their Potential for the Treatment of Chronic Diseases

orcid publication

Biological and Pharmacological Characterization of Benzothiazole-Based CK-1δ Inhibitors in Models of Parkinson’s Disease

orcid publication

Targeting PDE10A GAF Domain with Small Molecules: A Way for Allosteric Modulation with Anti-Inflammatory Effects

orcid publication

Medicinal and Biological Chemistry (MBC) Library: An Efficient Source of New Hits

orcid publication

TNFalpha disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice.

orcid publication

Cyclic Nucleotide-Specific Phosphodiesterases as Potential Drug Targets for Anti-Leishmania Therapy

orcid publication

Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: Potent butyrylcholinesterase inhibitors

orcid publication

Amyloid beta-induced impairments on mitochondrial dynamics, hippocampal neurogenesis, and memory are restored by phosphodiesterase 7 inhibition.

orcid publication

Identification of new allosteric sites and modulators of AChE through computational and experimental tools

orcid publication

1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders

orcid publication

Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa

orcid publication

The adiponectin promoter activator NP-1 induces high levels of circulating TNF alpha and weight loss in obese (fa/fa) Zucker rats

orcid publication

Recapitulation of Pathological TDP-43 Features in Immortalized Lymphocytes from Sporadic ALS Patients.

orcid publication

Deciphering the Inhibition of the Neuronal Calcium Sensor 1 and the Guanine Exchange Factor Ric8a with a Small Phenothiazine Molecule for the Rational Generation of Therapeutic Synapse Function Regulators

orcid publication

Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3 beta and Tau-Aggregation Inhibitors

orcid publication

High-fructose corn syrup consumption in adolescent rats causes bipolar-like behavioural phenotype with hyperexcitability in hippocampal CA3-CA1 synapses

orcid publication

QSAR modelling for drug discovery: Predicting the activity of LRRK2 inhibitors for Parkinson’s disease using cheminformatics approaches

orcid publication

Potential anti-Alzheimer effects of selected Lamiaceae plants through polypharmacology on glycogen synthase kinase-3 beta, beta-secretase, and casein kinase 1 delta

orcid publication

Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease

orcid publication

GSK-3 Inhibitors: From the Brain to the Retina and Back Again

orcid publication

Discovery of novel Schistosoma mansoni PDE4A inhibitors as potential agents against schistosomiasis

orcid publication

Correction of GSK3β in DM1 reduces the mutant RNA and improves postnatal survival of DMSXL mice

orcid publication

CHAPTER 8. Protein Kinase Inhibitors for the Treatment of Multiple Sclerosis

orcid publication

A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition

orcid publication

1-Aryl-3-(4-methoxybenzyl)ureas as potentially irreversible glycogen synthase kinase 3 inhibitors: Synthesis and biological evaluation

orcid publication

Tau Tubulin Kinase 1 (TTBK1), a new player in the fight against neurodegenerative diseases

orcid publication

Computer-aided molecular design of pyrazolotriazines targeting glycogen synthase kinase 3

orcid publication

A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential

orcid publication

Driving next-generation autophagy researchers towards translation (DRIVE), an international PhD training program on autophagy

orcid publication

QSAR Modelling to Identify LRRK2 Inhibitors for Parkinson’s Disease

orcid publication

TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral Sclerosis

orcid publication

Insights into real-time chemical processes in a calcium sensor protein-directed dynamic library

orcid publication

Theoretical and Experimental Approaches Aimed at Drug Design Targeting Neurodegenerative Diseases

orcid publication

From simple quinoxalines to potent oxazolo[5,4-f]quinoxaline inhibitors of glycogen-synthase kinase 3 (GSK3)

orcid publication

Towards discovery of new leishmanicidal scaffolds able to inhibit Leishmania GSK-3

orcid publication

Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline scaffold using complementary computational tools

orcid publication

Serum- and glucocorticoid-induced kinase 1, a new therapeutic target for autophagy modulation in chronic diseases

orcid publication

Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment

orcid publication

Benzothiazole-Based LRRK2 Inhibitors as Wnt Enhancers and Promoters of Oligodendrocytic Fate

orcid publication

Functionalized aromatic esters of the Amaryllidaceae alkaloid haemanthamine and their in vitro and in silico biological activity connected to Alzheimer’s disease

orcid publication

Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson’s Disease

orcid publication

COVID-19: Drug Targets and Potential Treatments

orcid publication

Cognitive enhancement, TAU phosphorylation reduction, and neuronal protection by the treatment of an LRRK2 inhibitor in a tauopathy mouse model

orcid publication

Targeting nuclear protein TDP-43 by cell division cycle kinase 7 inhibitors: A new therapeutic approach for amyotrophic lateral sclerosis

orcid publication

Mitophagy Modulation, a New Player in the Race against ALS

orcid publication

Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles

orcid publication

Therapeutic potential of novel Cell Division Cycle Kinase 7 inhibitors on TDP‐43‐related pathogenesis such as Frontotemporal Lobar Degeneration (FTLD) and amyotrophic lateral sclerosis (ALS)

orcid publication

Identification of potential inhibitors of protein-protein interaction useful to fight against Ebola and other highly pathogenic viruses

orcid publication

Structure-Based Design of Potent Selective Nanomolar Type-II Inhibitors of Glycogen Synthase Kinase-3β

orcid publication

Dynamics of Central Remyelination and Treatment Evolution in a Model of Multiple Sclerosis with Optic Coherence Tomography

orcid publication

Protein kinase inhibitors for amyotrophic lateral sclerosis therapy

orcid publication

Molecular Alterations in Sporadic and SOD1-ALS Immortalized Lymphocytes: Towards a Personalized Therapy

orcid publication

Improved Controlled Release and Brain Penetration of the Small Molecule S14 Using PLGA Nanoparticles

orcid publication

Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems

orcid publication

Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods

orcid publication

Allosteric Modulation of GSK-3β as a New Therapeutic Approach in Limb Girdle Muscular Dystrophy R1 Calpain 3-Related

orcid publication

Is drug repurposing really the future of drug discovery or is new innovation truly the way forward?

orcid publication

Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis

orcid publication

From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein‐Templated Synthesis

orcid publication

Identification of Niemann-Pick C1 protein as a potential novel SARS-CoV-2 intracellular target

orcid publication

Small molecule inhibitors of mammalian GSK-3β promote in vitro plant cell reprogramming and somatic embryogenesis in crop and forest species

orcid publication

Phenotypic Assay Leads to Discovery of Mitophagy Inducers with Therapeutic Potential for Parkinson’s Disease

orcid publication

GSK3 Inhibitor-Induced Dentinogenesis Using a Hydrogel

orcid publication

TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy

orcid publication

Kinase Inhibitors as Underexplored Antiviral Agents

orcid publication

Glycogen Synthase Kinase-3 Maleimide Inhibitors As Potential PET-Tracers for Imaging Alzheimer’s Disease: 11C-Synthesis and In Vivo Proof of Concept

Page 6 of 47
Computational Biology and Bioinformatics (BCB)

CONTACT | LEGAL NOTICE | COOKIES POLICY | DATA PROTECTION

© CSIC - Consejo Superior de Investigaciones Científicas. 2026 - All rights reserved. Powered by Scienseed
Go to Top